社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
曼妮小姐
IP属地:上海
+关注
帖子 · 3
帖子 · 3
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
曼妮小姐
曼妮小姐
·
2021-06-17
$洋葱集团(OG)$
唉,当初为何打这只新股?现在我打新都有阴影,错过了boss,看看万物新生能不能回点血
看
2,483
回复
2
点赞
6
编组 21备份 2
分享
举报
曼妮小姐
曼妮小姐
·
2020-11-30
$京东(JD)$
这和马上港股上市的京东健康有关吗
看
2,586
回复
3
点赞
点赞
编组 21备份 2
分享
举报
曼妮小姐
曼妮小姐
·
2020-09-29
希望一手能中
嘉和生物国际配售超购逾60倍,预计10月7日挂牌交易
9月29日讯,嘉和生物-B于今日截止招股,国际配售超购逾60倍,创欧康维视后记录。预计2020年10月7日在港交所上市。嘉和生物(Genor Biopharma Co. Ltd)是一家领先生物制药企业
嘉和生物国际配售超购逾60倍,预计10月7日挂牌交易
看
1,725
回复
1
点赞
点赞
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3557447708424107","uuid":"3557447708424107","gmtCreate":1594353721339,"gmtModify":1594353721339,"name":"曼妮小姐","pinyin":"mnxjmannixiaojie","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":12,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.08.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"上海","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":161562766,"gmtCreate":1623935498355,"gmtModify":1623935498355,"author":{"id":"3557447708424107","authorId":"3557447708424107","name":"曼妮小姐","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557447708424107","authorIdStr":"3557447708424107"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OG\">$洋葱集团(OG)$</a>唉,当初为何打这只新股?现在我打新都有阴影,错过了boss,看看万物新生能不能回点血","listText":"<a href=\"https://laohu8.com/S/OG\">$洋葱集团(OG)$</a>唉,当初为何打这只新股?现在我打新都有阴影,错过了boss,看看万物新生能不能回点血","text":"$洋葱集团(OG)$唉,当初为何打这只新股?现在我打新都有阴影,错过了boss,看看万物新生能不能回点血","images":[{"img":"https://static.tigerbbs.com/bb2e25ca1ac558af8ba5962b77e695dc","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":1,"link":"https://laohu8.com/post/161562766","isVote":1,"tweetType":1,"viewCount":2483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":391444214,"gmtCreate":1606751116338,"gmtModify":1703844234725,"author":{"id":"3557447708424107","authorId":"3557447708424107","name":"曼妮小姐","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557447708424107","authorIdStr":"3557447708424107"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/JD\">$京东(JD)$</a>这和马上港股上市的京东健康有关吗","listText":"<a href=\"https://laohu8.com/S/JD\">$京东(JD)$</a>这和马上港股上市的京东健康有关吗","text":"$京东(JD)$这和马上港股上市的京东健康有关吗","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/391444214","isVote":1,"tweetType":1,"viewCount":2586,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3460075005218803","authorId":"3460075005218803","name":"老虎诈骗坑人","avatar":"https://static.tigerbbs.com/4ca7523235dc23630767e8f431f60ba5","crmLevel":2,"crmLevelSwitch":0,"idStr":"3460075005218803","authorIdStr":"3460075005218803"},"content":"当然有关,京东健康是它旗下产业。然而,这并没什么卵用,该跌还是跌……","text":"当然有关,京东健康是它旗下产业。然而,这并没什么卵用,该跌还是跌……","html":"当然有关,京东健康是它旗下产业。然而,这并没什么卵用,该跌还是跌……"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":974772572,"gmtCreate":1601349725996,"gmtModify":1703824024716,"author":{"id":"3557447708424107","authorId":"3557447708424107","name":"曼妮小姐","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557447708424107","authorIdStr":"3557447708424107"},"themes":[],"htmlText":"希望一手能中","listText":"希望一手能中","text":"希望一手能中","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/974772572","repostId":"1105482182","repostType":4,"repost":{"id":"1105482182","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1601347079,"share":"https://www.laohu8.com/m/news/1105482182?lang=&edition=full","pubTime":"2020-09-29 10:37","market":"hk","language":"zh","title":"嘉和生物国际配售超购逾60倍,预计10月7日挂牌交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1105482182","media":"老虎资讯综合","summary":"9月29日讯,嘉和生物-B于今日截止招股,国际配售超购逾60倍,创欧康维视后记录。预计2020年10月7日在港交所上市。嘉和生物(Genor Biopharma Co. Ltd)是一家领先生物制药企业","content":"<p>9月29日讯,<a href=\"https://laohu8.com/S/06998\">嘉和生物-B</a>于今日截止招股,国际配售超购逾60倍,创欧康维视后记录。预计2020年10月7日在港交所上市。</p><p>嘉和生物(Genor Biopharma Co. Ltd)是一家领先生物制药企业, 已成功研发出靶向通路极具潜力的候选药物,涵盖全球前三大肿瘤靶点及前十款畅销药物中的五款。嘉禾不仅在药物研发方面表现突出,药物制造方面也极具优势,旗下工厂拥有行业级领先生物医药生产技术。</p><p>目前,嘉和生物最大股东为高瓴资本,高瓴资本旗下的HHJH持有嘉和近35%。除此之外,明星股东还有新加坡主权基金淡马锡、<a href=\"https://laohu8.com/S/300347\">泰格医药</a>、<a href=\"https://laohu8.com/S/601318\">中国平安</a>等。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>嘉和生物国际配售超购逾60倍,预计10月7日挂牌交易</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n嘉和生物国际配售超购逾60倍,预计10月7日挂牌交易\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-09-29 10:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>9月29日讯,<a href=\"https://laohu8.com/S/06998\">嘉和生物-B</a>于今日截止招股,国际配售超购逾60倍,创欧康维视后记录。预计2020年10月7日在港交所上市。</p><p>嘉和生物(Genor Biopharma Co. Ltd)是一家领先生物制药企业, 已成功研发出靶向通路极具潜力的候选药物,涵盖全球前三大肿瘤靶点及前十款畅销药物中的五款。嘉禾不仅在药物研发方面表现突出,药物制造方面也极具优势,旗下工厂拥有行业级领先生物医药生产技术。</p><p>目前,嘉和生物最大股东为高瓴资本,高瓴资本旗下的HHJH持有嘉和近35%。除此之外,明星股东还有新加坡主权基金淡马锡、<a href=\"https://laohu8.com/S/300347\">泰格医药</a>、<a href=\"https://laohu8.com/S/601318\">中国平安</a>等。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105482182","content_text":"9月29日讯,嘉和生物-B于今日截止招股,国际配售超购逾60倍,创欧康维视后记录。预计2020年10月7日在港交所上市。嘉和生物(Genor Biopharma Co. Ltd)是一家领先生物制药企业, 已成功研发出靶向通路极具潜力的候选药物,涵盖全球前三大肿瘤靶点及前十款畅销药物中的五款。嘉禾不仅在药物研发方面表现突出,药物制造方面也极具优势,旗下工厂拥有行业级领先生物医药生产技术。目前,嘉和生物最大股东为高瓴资本,高瓴资本旗下的HHJH持有嘉和近35%。除此之外,明星股东还有新加坡主权基金淡马锡、泰格医药、中国平安等。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1725,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题,可以获得更多曝光哦~如果您想创作优质文章,请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题,可以获得更多曝光哦~如果您想创作优质文章,请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题,可以获得更多曝光哦~如果您想创作优质文章,请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}